Jardiance, known generically as empagliflozin, is a medication widely used to improve glycemic control in adults with type 2 diabetes. As patients and healthcare providers increasingly seek cost-effective options, the question arises: when is Jardiance going generic? The Current Landscape of Jardiance Since its approval by the FDA in 2014, Jardiance has gained popularity due… Read More